Myers and Stauffer has implemented and maintained AAC-based pharmacy reimbursement programs since 2001. We currently contract with seven state Medicaid programs to perform these services. Most recently, the use of AAC-based rates for both brand and generic drug reimbursement has been implemented in four states. Myers and Stauffer helped make strategic decisions to gain maximum cost savings while preserving the best possible relationship with the pharmacy industry. We provided critical assistance in reimbursement policy design and subsequent rule making. After significant review and analysis of acquisition cost data, drug utilization and statistical analysis. We have continuously set ingredient reimbursement rates specific to each state.
Utilizing average acquisition costs in determining MAC rates provides many benefits:
Myers and Stauffer performs a rigorous and timely review of MAC rates that includes examination of and comparison with current acquisition cost data, published pricing information, prescription drug patent expirations, and other state-specific market indicators. Our work with multiple Medicaid fiscal agents allows us to quickly and effectively transmit rate files to the state’s contractors for implementation in claims processing.